A dose-finding study of efficacy and safety of F13640 in patients with moderate to severe painful peripheral diabetic polyneuropathy

Registry ID
EUCTR2009-012123-28
Source registry
EUCTR
Status
Completed
Phase
PHASE2
Sponsor
Institut de Recherche Pierre Fabre
Start date
2010-04-07
Completion date
2010-12-08
Last update
2026-08-16

Conditions

Summary

The first study objective is to define the dose-response relationship of F13640 compared to a placebo with respect to analgesic efficacy and safety in patients with moderate to severe painful peripheral diabetic polyneuropathy.

Locations

View on source registry